Ethical Implications of Editing Genetic Factors in Neurodegenerative Diseases for Future Immunologists

1. Introduction 1.1 Background and Context 1.2 Objectives and Research Questions 1.3 Methodology Overview 2. Neurodegenerative Diseases Overview 2.1 Definition and Characteristics 2.2 Common Neurodegenerative Diseases 2.3 Current Treatment Approaches 3. Genetic Editing Technologies 3.1 CRISPR-Cas9 Mechanism 3.2 Limitations of Current Technologies 3.3 Future Prospects in Genetics 4. Ethical Implications in Genetic Editing 4.1 Patient Consent Considerations 4.2 Potential for Genetic Discrimination 4.3 Long-term Effects and Unknowns 5. Impact on Future Immunologists 5.1 Educational Requirements 5.2 Changing Role in Patient Care 5.3 Professional Ethical Challenges 6. Case Studies and Current Research 6.1 Case Study of Alzheimer’s Disease 6.2 Parkinson’s Disease Research Initiatives 6.3 Other Relevant Case Studies 7. Policy and Regulatory Framework 7.1 Current International Guidelines 7.2 National Laws and Regulations 7.3 Proposals for Policy Enhancements 8. Conclusions and Recommendations 8.1 Summary of Findings 8.2 Future Research Directions 8.3 Final Recommendations